These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33438140)

  • 1. AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype?
    Zhang J; Chen Y; Chen J; Huang X; Wang H; Li Y; Liu W; Feng H
    Neurol Sci; 2021 Mar; 42(3):863-869. PubMed ID: 33438140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients.
    Li M; Ren L; Zhang Y; Lv J; Fang H; Zhang J; Zhao X; Han J; Huang P; Du Y; Zhang Q; Yang J; Zhang Y; Gao F
    Clin Neurol Neurosurg; 2018 Sep; 172():69-73. PubMed ID: 29986198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at sampling and sex distribution of AChRAb vs. MuSKAb myasthenia gravis in a large Greek population.
    Belimezi M; Kalliaropoulos A; Jiménez J; Garcia I; Mentis AA; Chrousos GP
    Clin Neurol Neurosurg; 2021 Sep; 208():106847. PubMed ID: 34343914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of MuSK antibody-positive myasthenia gravis in Taiwan.
    Huang YC; Yeh JH; Chiu HC; Chen WH
    J Formos Med Assoc; 2008 Jul; 107(7):572-5. PubMed ID: 18632417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018.
    Yoshikawa H; Adachi Y; Nakamura Y; Kuriyama N; Murai H; Nomura Y; Sakai Y; Iwasa K; Furukawa Y; Kuwabara S; Matsui M;
    PLoS One; 2022; 17(9):e0274161. PubMed ID: 36129914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR.
    Martignago S; Fanin M; Albertini E; Pegoraro E; Angelini C
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):103-10. PubMed ID: 19187062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis.
    Muppidi S; Wolfe GI
    Front Neurol Neurosci; 2009; 26():109-119. PubMed ID: 19349708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review.
    Lu Y; Ran H; Yang W; Ma Q; Qiu L; Ou C; Chen P; Lin Z; Liu W
    Neuromuscul Disord; 2020 Jul; 30(7):534-538. PubMed ID: 32387283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete stable remission and autoantibody specificity in myasthenia gravis.
    Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
    Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.
    Feng HY; Wang HY; Liu WB; He XT; Huang X; Luo CM; Li Y
    Neurol Sci; 2013 Jun; 34(6):919-24. PubMed ID: 22829131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review.
    Santilli A; Stitt D
    Neurologist; 2021 Sep; 26(5):175-177. PubMed ID: 34491934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.
    Morren J; Li Y
    Muscle Nerve; 2018 Sep; 58(3):344-358. PubMed ID: 29461627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW; Morsch M; Phillips WD
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis.
    Iijima S
    Pediatr Neonatol; 2021 Nov; 62(6):581-590. PubMed ID: 34272198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile anti-MuSK positive myasthenia gravis in a patient with autoimmune polyendocrinopathy type 3.
    Duman O; Koken R; Baran RT; Haspolat S; Topaloglu H
    Eur J Paediatr Neurol; 2014 Jul; 18(4):526-8. PubMed ID: 24685514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody].
    Konishi T
    Brain Nerve; 2011 Jul; 63(7):695-704. PubMed ID: 21747139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.